[HTML][HTML] Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
…, K Hørslev-Petersen, RK Luukkainen… - Arthritis research & …, 2008 - Springer
Introduction We analyzed the prevalence of cardiovascular (CV) disease in patients with
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of …
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of …
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial
…, M Korpela, L Laasonen, H Julkunen, R Luukkainen… - The Lancet, 1999 - thelancet.com
Background The treatment of rheumatoid arthritis should aim at clinical remission. This
multicentre, randomised trial with 2-year follow-up sought evidence on the efficacy and tolerability …
multicentre, randomised trial with 2-year follow-up sought evidence on the efficacy and tolerability …
Fecal microbiota in early rheumatoid arthritis
…, E Munukka, M Korkeamäki, R Luukkainen… - The Journal of …, 2008 - jrheum.org
Objective To compare the composition of intestinal microbiota of patients with early rheumatoid
arthritis (RA) or fibromyalgia (FM), fecal samples were collected from 51 patients with RA …
arthritis (RA) or fibromyalgia (FM), fecal samples were collected from 51 patients with RA …
[HTML][HTML] Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study
…, IMM Laurindo, J Lazovskis, R Luukkainen… - Arthritis research & …, 2010 - Springer
Introduction Work disability is a major consequence of rheumatoid arthritis (RA), associated
not only with traditional disease activity variables, but also more significantly with …
not only with traditional disease activity variables, but also more significantly with …
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty‐four countries
…, K Hørslev‐Petersen, RK Luukkainen… - Arthritis & …, 2008 - Wiley Online Library
Objective To compare the performance of different definitions of remission in a large
multinational cross‐sectional cohort of patients with rheumatoid arthritis (RA). Methods The …
multinational cross‐sectional cohort of patients with rheumatoid arthritis (RA). Methods The …
Impact of initial aggressive drug treatment with a combination of disease‐modifying antirheumatic drugs on the development of work disability in early rheumatoid …
…, M Korpela, H Julkunen, R Luukkainen… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To compare the efficacy of therapy with a combination of disease‐modifying
antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work …
antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work …
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study
D Nordström, A Knight, R Luukkainen… - The Journal of …, 2012 - jrheum.org
Objective. To study the efficacy of anakinra versus disease-modifying antirheumatic drugs (DMARD)
in refractory adult-onset Still’s disease (AOSD). Methods. In a 24-week study, 22 …
in refractory adult-onset Still’s disease (AOSD). Methods. In a 24-week study, 22 …
Interleukin‐10 functions as an antiinflammatory cytokine in rheumatoid synovium
P Isomäki, R Luukkainen, R Saario… - … : Official Journal of …, 1996 - Wiley Online Library
Objective. Interleukin‐10 (IL‐10) is an antiinflammatory cytokine that has been shown to
play a role in rheumatoid arthritis (RA). We therefore investigated the effects of IL‐10 on the …
play a role in rheumatoid arthritis (RA). We therefore investigated the effects of IL‐10 on the …
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo …
…, R Luosujärvi, R Luukkainen… - Annals of the …, 2013 - ard.bmj.com
Objective Early treatment of patients with rheumatoid arthritis (RA) with combination
treatment starting with methotrexate, sulfasalazine, hydroxychloroquine and prednisolone (FIN-…
treatment starting with methotrexate, sulfasalazine, hydroxychloroquine and prednisolone (FIN-…
Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis
…, R Merilahti‐Palo, R Luukkainen… - … : Official Journal of …, 1998 - Wiley Online Library
Objective To assess the persistence of bacterial antigens in peripheral blood cells from
patients with Yersinia enterocolitica O:3‐triggered reactive arthritis (ReA). Methods Peripheral …
patients with Yersinia enterocolitica O:3‐triggered reactive arthritis (ReA). Methods Peripheral …